{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:06:09Z","timestamp":1791644769344,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ophtha.2015.09.029","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T06:02:08Z","timestamp":1446530528000},"page":"141-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress"],"prefix":"10.1016","volume":"123","clinical-trial-number":[{"clinical-trial-number":"2013-002183-63","registry":"10.18810\/euctr"},{"clinical-trial-number":"nct02051023","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jos\u00e9","family":"Pinto-Fraga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"L\u00f3pez-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"L\u00f3pez-de-la-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Enr\u00edquez-de-Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Calonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.ophtha.2015.09.029_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1542-0124(12)70620-1","article-title":"Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment","volume":"7","author":"Lemp","year":"2009","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2015.09.029_bib2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0161-6420(98)96016-X","article-title":"The epidemiology of dry eye in Melbourne, Australia","volume":"105","author":"McCarty","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.09.029_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0161-6420(03)00262-8","article-title":"Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study","volume":"110","author":"Lin","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.09.029_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.toxlet.2010.09.001","article-title":"Ocular discomfort by environmental and personal risk factors altering the precorneal tear film","volume":"199","author":"Wolkoff","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.ophtha.2015.09.029_bib5","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ophtha.2008.06.022","article-title":"Prevalence of dry eye disease among Japanese visual display terminal users","volume":"115","author":"Uchino","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.09.029_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1542-0124(12)70085-X","article-title":"Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Pflugfelder","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2015.09.029_bib7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.82.6.666","article-title":"Frequent association of delayed tear clearance in ocular irritation","volume":"82","author":"Prabhasawat","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.09.029_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/jop.2006.0091","article-title":"Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Hong","year":"2007","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2015.09.029_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/ICO.0b013e3181b765a6","article-title":"Preservative-free low-dose dexamethasone for the treatment of chronic ocular surface disease refractory to standard therapy","volume":"29","author":"Jonisch","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2015.09.029_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3349\/ymj.2014.55.1.203","article-title":"Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ophtha.2015.09.029_bib12","first-page":"751","article-title":"Nonpreserved topical steroids and punctual occlusion for severe keratoconjunctivitis sicca","volume":"75","author":"Sainz de la Maza Serra","year":"2000","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1631\/jzus.2006.B0675","article-title":"A\u00a0clinical study of the efficacy of topical corticosteroids on dry eye","volume":"8","author":"Yang","year":"2006","journal-title":"J\u00a0Zhejiang Univ Sci B"},{"key":"10.1016\/j.ophtha.2015.09.029_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ICO.0b013e31818c69ef","article-title":"Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye","volume":"31","author":"Byun","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2015.09.029_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajo.2015.04.008","article-title":"Effects of dry eye therapies on environmentally induced ocular surface disease","volume":"160","author":"Moore","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(03)00326-X","article-title":"The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study","volume":"136","author":"Avunduk","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A\u00a0randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ophtha.2005.09.033","article-title":"Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients","volume":"113","author":"Lee","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.09.029_bib19","first-page":"633","article-title":"Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial","volume":"5","author":"Patane","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5301\/ejo.5000229","article-title":"Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sj\u00f6gren syndrome","volume":"23","author":"Aragona","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ICL.0000000000000049","article-title":"Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%","volume":"40","author":"Sheppard","year":"2014","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ophtha.2015.09.029_bib22","series-title":"Dry Eye and Ocular Surface Disorders","year":"2004"},{"key":"10.1016\/j.ophtha.2015.09.029_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajo.2014.01.001","article-title":"Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions","volume":"157","author":"L\u00f3pez-Miguel","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib24","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1167\/iovs.12-11322","article-title":"Factors predicting the ocular surface response to desiccating environmental stress","volume":"54","author":"Alex","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2015.09.029_bib25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1167\/iovs.12-11361","article-title":"Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease","volume":"54","author":"Tes\u00f3n","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2015.09.029_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2015.09.029_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2015.09.029_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2015.09.029_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00006324-200212000-00007","article-title":"Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen","volume":"79","author":"Jones","year":"2002","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2015.09.029_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0275-5408(97)00066-5","article-title":"Grading scales for contact lens complications","volume":"18","author":"Efron","year":"1998","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.ophtha.2015.09.029_bib32","doi-asserted-by":"crossref","first-page":"789623","DOI":"10.1155\/2012\/789623","article-title":"Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate","volume":"2012","author":"Comstock","year":"2012","journal-title":"Int J Inflam"},{"key":"10.1016\/j.ophtha.2015.09.029_bib33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","article-title":"Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance","volume":"93","author":"Awan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib34","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1167\/iovs.11-8412","article-title":"Corneal fluorescein staining correlates with visual function in dry eye patients","volume":"16","author":"Kaido","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2015.09.029_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00161022","article-title":"Efficacy of levocabastine in conjunctival provocation studies","volume":"82","author":"Janssens","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.09.029_bib37","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ophtha.2015.09.029_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1542-0124(12)70004-6","article-title":"Challenges and pitfalls in clinical trials of treatments for dry eye","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocul Surf"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642015011070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642015011070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T07:47:20Z","timestamp":1621064840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642015011070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0161642015011070"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.029","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}